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Lactating adenoma is a rare benign breast lesion that most often presents as a small (up to 3 cm), solid, well-circumscribed, 
solitary, painless, mobile, lobulated mass. The highest incidence occurs in primiparous women (20 to 40 years old) 
during the third trimester of pregnancy. However, in the rare case presented herein, in addition to its giant size (more 
than 10 centimeters on palpation), this lactating adenoma is distinctive due to the presence of multiple nodules, poorly 
defined ultrasonographic margins, worrisome radiologic features, growth since early pregnancy, presence of infarction 
and association with chronic mastitis. From the clinical-radiologic perspective, the differential diagnoses included abscess 
associated with puerperal mastitis, phyllodes tumor, and galactocele. Biopsy was performed, and pathologic examination 
revealed the classic characteristics of lactating adenoma with multiple infarcted areas, leading to an unexpected confirmed 
case of giant lactating adenoma. 
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INTRODUCTION
Lactating adenoma (LA) is a rare benign breast 
mass1 that usually affects women (20 to 40 years 
old) during the third trimester of pregnancy or while 
breastfeeding.2,3 Although it is most commonly 
reported in primigravid women, there have been 
reports in multigravid women. The exact nature of 
lactating adenoma remains unknown, but some 
postulate that it may originate as a new lesion from 
pre-existing adenomas.3
Lactating adenoma usually presents as a small (about 
3 cm), solid, painless, well-defined, lobulated, mobile 
nodule. This nodule usually grows slowly and may or 
may not be palpable.2-5 Axillary lymph nodes are usually 
not palpable.
Biopsy is the current gold standard test used to 
diagnose lactating adenoma and should not be delayed 
until after delivery.6 However, ultrasound (US) and 
mammography applying the BIRADS classification (Breast 
Imaging Reporting and Data System) are useful modalities 
to confirm the need to proceed with tissue sampling.2,5
CASE REPORT
A 20-year-old, primiparous woman presented 
during her third postpartum month with firm right 
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breast enlargement. She was exclusively breastfeeding. 
She noted that the enlargement began during the first 
trimester of her pregnancy. On physical examination, a 
bulky and firm mass in the right upper lateral quadrant 
was palpated to be more than 10 cm. There were no 
signs of inflammation in the overlying skin. There was a 
fistula extruding pasty secretions which were assumed 
to be from an abscess resulting from puerperal mastitis. 
Adjacent to the fistular ostium, there was a rubbery 
mobile mass measuring 3 cm on palpation.
Right breast ultrasonography showed a hypoechoic 
and heterogeneous mass in the upper lateral quadrant 
with poorly defined edges measuring 8.8 x 5.9 cm 
and an adjacent nodule measuring 6.3 x 3.3 cm 
described as an atypical lymph node enlargement 
given a BI-RADS 5 classification, which indicates a high 
suspicion of cancer.
Clinically, the working diagnosis was a phyllodes 
tumor. Other differential diagnoses included abscess 
associated with puerperal mastitis and galactocele. 
Therefore, resection of the lesions was performed. 
Gross examination of the surgical specimens showed 
two masses; the larger (Figure 1) weighed 350g and 
measured 11 x 10 x 6 cm, while the smaller weighed 
42g and measured 3.0 x 4.5 x 2.0 cm. Both lesions 
were well-defined, brown, firm, and rubbery. The 
cut surface showed a compact and lobulated mass 
with cystic areas measuring 6.0 x 4.5 cm, containing 
pasty, friable and sometimes yellow contents, and 
surface fistulation. The histologic analysis revealed 
two lactating adenomas (Figure 2), with an area of 
ischemic infarction and chronic suppurative mastitis 
in the larger lesion. Two months after surgery, there 
was a residual 3 cm nodule filled with serosanguinous 
fluid. Drainage was performed. Outpatient monitoring 
Figure 1. Gross view of the surgical specimens. A – External surface; The larger mass measured 11 x 10 x 6 cm, 
while the smaller mass measured 3.0 x 4.5 x 2.0 cm. Both were well-defined brown and lobulated nodules with 
pseudo-capsule. B – Cut section of the larger mass; Heterogeneous solid mass with small peripheral cysts and 
central, white chalk-like necrotic area (scale bar = 11 cm).
Figure 2. Photomicrograph of the surgical specimen. A – Lactating adenoma; proliferation of intralobular tubules 
and acini, closely packed and intermixed with delicate fibrous stroma. Some acini with lumina containing eosinophilic 
secretions (H&E, 40x); B – Microscopic appearance of grossly chalk-like area demonstrating coagulative necrosis and 
a hyperbasophilic rim of dystrophic calcification (H&E, 40x).
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showed progressive size reduction of the residual 
nodule and no further complications.
DISCUSSION
Lactating adenoma is a nodular lesion formed of 
tubules and acini surrounded by myoepithelial cells and 
lined by vacuolated epithelial cells, containing abundant 
intraluminal secretion. It usually spontaneously 
regresses and is rarely accompanied by axillary 
lymphadenopathy.2,7 The typical presentation is a 
painless, solitary, mobile, well-circumscribed breast 
mass smaller than 5 cm in diameter. Rarely, they may be 
multiple or bilateral. It occurs during the third trimester 
of pregnancy, as well as during breast feeding.6 In 
our case, in addition to its unusually large size (more 
than 10 cm on palpation), this lactating adenoma 
presented as multiple nodules. Moreover, this lesion 
had poorly-defined ultrasonographic margins (BI-RADS 
5), its growth began in early pregnancy, and contained 
areas of necrosis and chronic mastitis.
Lactating adenoma is often a diagnosis of 
exclusion, after ruling out other benign or malignant 
causes of a breast mass. In this setting, these entities 
include fibroadenoma (although lactating adenoma 
consists of a benign growth of tubules and acini5 
with scarce stromal epithelial cells), tubular adenoma 
(which does not show lactational changes such as 
intracytoplasmic or supranuclear vacuolization),4,8 
carcinoma and breast cancer, among other diseases. It 
is worth emphasizing that any breast lesion that occurs 
during lactation should be thoroughly investigated due 
to the increased risk of carcinomas that metastasize 
from lactating breasts.9 The diagnosis of lactating 
adenoma, in this case, was not initially expected 
due to the extremely atypical clinical presentation 
and unorthodox BI-RADS 5 classification, while 
the maximum US category reported from lactating 
adenomas has been BI-RADS 4b.4
After the diagnostic biopsy, the treatments range 
from medication to surgery, depending on the case. 
Pharmacologic treatments are based on prolactin 
inhibitors such as bromocriptine3,10 and cabergoline,4 
and tend to have a favorable response. However, 
the use of anti-prolactin therapy should be weighed 
with the patient’s desire to breastfeed. Most cases of 
lactating adenoma spontaneously resolve; nonetheless, 
if it persists, grows rapidly, and/or produces marked 
discomfort, surgical removal is recommended and 
can be done during pregnancy without harm to the 
mother nor fetus. Surgical removal does not impair 
breastfeeding.3,5 However, if possible, excision should 
be postponed to the postpartum period. The patient 
should be followed-up within a few months to exclude 
complications or relapse.
CONCLUSION
We present a rare case of lactating adenoma 
which was highly suspicious for malignancy at clinical 
presentation and ultrasonography. The dominant 
mass with satellite nodules, necrotic center, ill-defined 
borders and related lymphadenopathy were interpreted 
as BI-RADS 5 category on ultrasonography. Biopsy 
unexpectedly revealed benign-appearing lactating 
adenoma. The presence of multiple nodules, inflammatory 
edema, and necrosis due to ischemic central area of rapid 
enlarging mass contributed to the high suspicion of 
malignancy before biopsy was performed.
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